+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Chronic Kidney Disease - Competitive Landscape, 2026 - Product Thumbnail Image

Chronic Kidney Disease - Competitive Landscape, 2026

  • Report
  • January 2026
  • 190 Pages
  • Global
From
From
Peptide Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Peptide Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
From
Peptide Therapeutics Market 2024-2028 - Product Thumbnail Image

Peptide Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 148 Pages
  • Global
From
Protein Therapeutics Market 2024-2028 - Product Thumbnail Image

Protein Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 191 Pages
  • Global
From
From
From
From
GLP-1 Receptor Agonist - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Receptor Agonist - Global Strategic Business Report

  • Report
  • April 2026
  • 483 Pages
  • Global
From
From
Clinical Trials Market in the US 2025-2029 - Product Thumbnail Image

Clinical Trials Market in the US 2025-2029

  • Report
  • February 2025
  • 166 Pages
  • United States
From
Loading Indicator